A stable and safe skin antiseptic solution comprises chlorhexidine,pharmaceuticallyacceptable salts of chlorhexidine (e.g. chlorhexidine digluconate), or amixture thereof, dimethyllauramide/myristarnide, and water. Said solution is essentially free ofcoconut oildiethanolamine concentrate ("cocamide DEA"), a known carcinogen. The activeantisepticingredient, chlorhexidine (or its salts), is a di(4-chlorophenyldiguanido)compound. Thefunctions of dimethyl lauramide/myristamide in said solution include, but notlimited to, anaesthetics enhancer, a foam stabilizer, a solubilizer, and a fragrance. Saidsolution is specificallyformulated to be safe with a reduced risk of carcinogenicity, and be capableof producing a stableand long lasting foam. The active antiseptic agent is evenly distributed insaid solution and insaid foam, respectively.
